Nonmyeloablative Haploidentical Transplant Followed by MLN9708

NCT02169791 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Chronic Leukemia
Myelodysplastic Syndrome
Lymphomas
Multiple Myeloma

Interventions

DRUG: MLN9708

Sponsor

Northside Hospital, Inc.

Collaborators

[object Object]